Diffusion Pharmaceuticals Financial Health

Short Term Liabilities: DFFN's short term assets ($26.3M) exceed its short term liabilities ($2.3M).

Long Term Liabilities: DFFN has no long term liabilities.

Debt Level: DFFN is debt free.

Reducing Debt: DFFN has no debt compared to 5 years ago when its debt to equity ratio was 8.7%.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DFFN has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: DFFN has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 6.2% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.